Currently at CMC Biologics as a Process Development Scientist, Dr. Michelle Najera oversees both early-phase and late-phase biotherapeutic processing. In her role, Dr. Najera develops protein purification processes to include chromatography processing and scale-up to cGMP manufacturing. Before joining CMC Biologics, Dr. Najera worked at Genentech in Manufacturing Sciences. She earned her undergraduate degree in chemical engineering at University of California Los Angeles and her Ph.D. at University of Pittsburgh.